## KEITH CHAN

| | Title| Adjunct Associate Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Molecular & Cellular Biology  
Address| Cedars-Sinai Medical Center , 8700 Bever  
Los Angeles, CA 90058  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=PahhwWfELcXwQpo%3d&rnd=e8d0264e-a54a-4cda-b75c-ed3cbb8a67b8)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=266205)  
  

Other Positions| Title| Adjunct Associate Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Urology  
Division| Urology  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Research  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
research activities and funding

U54CA274375 (CHAN, KEITH SYSON)Sep 22, 2022 - Aug 31, 2027NIH  
The stromal microenvironment as a co-organizer of bladder carcinogenesis and
progression  
Role: Principal Investigator  
---  
  
* * *  
  
R01CA255609 (CHAN, KEITH SYSON)Aug 1, 2021 - Jul 31, 2026NIH  
Targeting tumor repopulation and the immune microenvironment to overcome
chemoresistance  
Role: Principal Investigator  
  
* * *  
  
R01CA175397 (CHAN, KEITH SYSON)Sep 30, 2013 - Apr 30, 2026NIH  
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting
Approaches  
Role: Principal Investigator  
  
* * *  
  
R00CA129640 (CHAN, KEITH SYSON)Aug 15, 2007 - Aug 31, 2012NIH  
Identification and characterization of bladder cancer stem cells  
Role: Principal Investigator  
  
* * *  
  
K99CA129640 (CHAN, KEITH SYSON)Aug 15, 2007 - Aug 31, 2009NIH  
Identification and characterization of bladder cancer stem cells  
Role: Principal Investigator  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Ranganathan S, Riveros C, Xu J, Hu S, Geng M, Huang E, Melchiode Z, Zhang J, [Efstathiou E](https://profiles.viictr.org/profile/12583454), **Chan KS** , Wallis CJD, Sonpavde G, Satkunasivam R. Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience. Urol Oncol. 2024 Sep; 42(9):291.e13-291.e25. PMID: [38763801](//www.ncbi.nlm.nih.gov/pubmed/38763801).

Citations:  Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  2. Riveros C, Ranganathan S, Haque W, Huang E, Xu J, Kulkarni GS, Geng M, Anis M, Muhammad T, **Chan KS** , Farach A, Teh BS, [Miles BJ](https://profiles.viictr.org/profile/268161), Klaassen Z, Sonpavde GP, Wallis CJD, Satkunasivam R. Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation. Can Urol Assoc J. 2024 Feb; 18(2):17-24. PMID: [37931278](//www.ncbi.nlm.nih.gov/pubmed/37931278); PMCID: [PMC10841558](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10841558).

Citations:

  3. Heiser CN, Simmons AJ, Revetta F, McKinley ET, Ramirez-Solano MA, Wang J, Kaur H, Shao J, Ayers GD, Wang Y, Glass SE, Tasneem N, Chen Z, Qin Y, Kim W, Rolong A, Chen B, Vega PN, Drewes JL, Markham NO, Saleh N, Nikolos F, Vandekar S, Jones AL, Washington MK, Roland JT, **Chan KS** , Sch?rpf T, Sears CL, Liu Q, Shrubsole MJ, Coffey RJ, Lau KS. Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors. Cell. 2023 12 07; 186(25):5620-5637.e16. PMID: [38065082](//www.ncbi.nlm.nih.gov/pubmed/38065082); PMCID: [PMC10756562](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10756562).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/38065082/citedby/) Fields:

Cel Cell Biology

Translation:Humans

  4. Piras R, Ko EY, Barrett C, De Simone M, Lin X, Broz MT, Tessaro FHG, Castillo-Martin M, Cordon-Cardo C, Goodridge HS, Di Vizio D, Batish M, Lawrenson K, Chen YG, **Chan KS** , Guarnerio J. circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment. Nat Commun. 2022 11 25; 13(1):7243. PMID: [36433954](//www.ncbi.nlm.nih.gov/pubmed/36433954); PMCID: [PMC9700836](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9700836).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36433954/citedby/) Fields:

Bio BiologySci Science

Translation:Humans

  5. You S, Kim M, Hoi XP, Lee YC, Wang L, Spetzler D, Abraham J, Magee D, Jain P, Galsky MD, **Chan KS** , Theodorescu D. Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy. J Natl Cancer Inst. 2022 10 06; 114(10):1380-1391. PMID: [35918812](//www.ncbi.nlm.nih.gov/pubmed/35918812); PMCID: [PMC9552307](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9552307).

Citations:

  6. Lee YC, Lam HM, Rosser C, Theodorescu D, Parks WC, **Chan KS**. The dynamic roles of the bladder tumour microenvironment. Nat Rev Urol. 2022 09; 19(9):515-533. PMID: [35764795](//www.ncbi.nlm.nih.gov/pubmed/35764795); PMCID: [PMC10112172](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10112172).

Citations:  Fields:

Uro Urology

  7. You S, Kim M, Widen S, Yu A, Galvan GC, Choi-Kuaea Y, Eyzaguirre EJ, McConkey DJ, Choi W, Theodorescu D, **Chan KS** , Shan Y, Tyler DS, De Hoedt AM, Freedland SJ, Williams SB, Dyrskj?t L. Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients. Urol Oncol. 2022 09; 40(9):410.e19-410.e27. PMID: [35618577](//www.ncbi.nlm.nih.gov/pubmed/35618577); PMCID: [PMC9741768](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9741768).

Citations:  Fields:

Neo NeoplasmsUro Urology

  8. Tyner JW, Haderk F, Kumaraswamy A, Baughn LB, Van Ness B, Liu S, Marathe H, Alumkal JJ, Bivona TG, **Chan KS** , Druker BJ, Hutson AD, Nelson PS, Sawyers CL, Willey CD. Understanding Drug Sensitivity and Tackling Resistance in Cancer. Cancer Res. 2022 04 15; 82(8):1448-1460. PMID: [35195258](//www.ncbi.nlm.nih.gov/pubmed/35195258); PMCID: [PMC9018544](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9018544).

Citations:

  9. Girardi DM, Niglio SA, Mortazavi A, Nadal R, Lara P, Pal SK, Saraiya B, Cordes L, Ley L, Ortiz OS, Cadena J, Diaz C, Bagheri H, Redd B, Steinberg SM, Costello R, **Chan KS** , Lee MJ, Lee S, Yu Y, Gurram S, Chalfin HJ, Valera V, Figg WD, Merino M, Toubaji A, Streicher H, Wright JJ, Sharon E, Parnes HL, Ning YM, Bottaro DP, Cao L, Trepel JB, Apolo AB. Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy. Clin Cancer Res. 2022 04 01; 28(7):1353-1362. PMID: [35031545](//www.ncbi.nlm.nih.gov/pubmed/35031545); PMCID: [PMC9365339](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9365339).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  10. Nikolos F, Hayashi K, Hoi XP, Alonzo ME, Mo Q, Kasabyan A, Furuya H, Trepel J, Di Vizio D, Guarnerio J, Theodorescu D, Rosser C, Apolo A, Galsky M, **Chan KS**. Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors. Nat Commun. 2022 03 28; 13(1):1487. PMID: [35347124](//www.ncbi.nlm.nih.gov/pubmed/35347124); PMCID: [PMC8960844](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8960844).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35347124/citedby/) Fields:

Bio BiologySci Science

Translation:HumansAnimalsCells

  11. [Ho SR](https://profiles.viictr.org/profile/3009889), Lee YC, [Ittmann MM](https://profiles.viictr.org/profile/269566), [Lin FT](https://profiles.viictr.org/profile/269919), **Chan KS** , [Lin WC](https://profiles.viictr.org/profile/266112). RNF144A deficiency promotes PD-L1 protein stabilization and carcinogen-induced bladder tumorigenesis. Cancer Lett. 2021 11 01; 520:344-360. PMID: [34400221](//www.ncbi.nlm.nih.gov/pubmed/34400221); PMCID: [PMC9420248](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9420248).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34400221/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  12. Gouin KH, Ing N, Plummer JT, Rosser CJ, Ben Cheikh B, Oh C, Chen SS, **Chan KS** , Furuya H, Tourtellotte WG, Knott SRV, Theodorescu D. An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer. Nat Commun. 2021 08 12; 12(1):4906. PMID: [34385456](//www.ncbi.nlm.nih.gov/pubmed/34385456); PMCID: [PMC8361097](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8361097).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34385456/citedby/) Fields:

Bio BiologySci Science

Translation:HumansCells

  13. Hayashi K, Nikolos F, **Chan KS**. Inhibitory DAMPs in immunogenic cell death and its clinical implications. Cell Stress. 2021 Mar 22; 5(4):52-54. PMID: [33821233](//www.ncbi.nlm.nih.gov/pubmed/33821233); PMCID: [PMC8012883](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8012883).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33821233/citedby/)

  14. Mo Q, Li R, Adeegbe DO, Peng G, **Chan KS**. Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy. Commun Biol. 2020 12 17; 3(1):784. PMID: [33335285](//www.ncbi.nlm.nih.gov/pubmed/33335285); PMCID: [PMC7746703](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7746703).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33335285/citedby/)
Translation:Humans

  15. Robertson AG, Seiler R, Hoadley KA, Al-Ahmadie H, Choi W, Eriksson P, Mo Q, Kardos J, Zlotta A, [Dinney CP](https://profiles.viictr.org/profile/12583684), Bellmunt J, Powles T, **Chan KS** , Kim WY, McConkey DJ, Black PC, [Lerner SP](https://profiles.viictr.org/profile/267959), Real FX, Aine M, [Czerniak B](https://profiles.viictr.org/profile/12582882), Gibb EA, Kim J, Kwiatkowski DJ, Lebret T, Siefker-Radtke AA, Sirab N, Taber A, [Weinstein JN](https://profiles.viictr.org/profile/12583120), Kamoun A, de Reyni?s A, Allory Y, Sj?dahl G, Groeneveld CS, Castro MAA, Fontugne J, Hartmann A, Malats N, Dyrskj?t L, H?glund M, Radvanyi F, Bernard-Pierrot I, Liedberg F. Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5. Eur Urol. 2020 04; 77(4):436-438. PMID: [32037144](//www.ncbi.nlm.nih.gov/pubmed/32037144).

Citations:  Fields:

Uro Urology

Translation:Humans

  16. Furuya H, Hayashi K, Shimizu Y, Kim N, Tsukikawa Y, Chen R, Sun Y, Chan OTM, Pagano I, Peres R, Hokutan K, **Chan KS** , Rosser CJ, Igari F. Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model. J Transl Med. 2020 02 05; 18(1):57. PMID: [32024545](//www.ncbi.nlm.nih.gov/pubmed/32024545); PMCID: [PMC7003426](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7003426).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32024545/citedby/) Fields:

Med Medicine (General)

Translation:Animals

  17. Furuya H, Chan OTM, Hokutan K, Tsukikawa Y, Chee K, Kozai L, **Chan KS** , Dai Y, Wong RS, Rosser CJ. Prognostic Significance of Lymphocyte Infiltration and a Stromal Immunostaining of a Bladder Cancer Associated Diagnostic Panel in Urothelial Carcinoma. Diagnostics (Basel). 2019 Dec 28; 10(1). PMID: [31905599](//www.ncbi.nlm.nih.gov/pubmed/31905599); PMCID: [PMC7168167](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7168167).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31905599/citedby/)

  18. Robertson AG, Seiler R, Hoadley KA, Al-Ahmadie H, Choi W, Eriksson P, Mo Q, Kardos J, Zlotta A, [Dinney CP](https://profiles.viictr.org/profile/12583684), Bellmunt J, Powles T, **Chan KS** , Kim WY, McConkey DJ, Black PC, [Lerner SP](https://profiles.viictr.org/profile/267959), Real FX, Bladder Cancer Molecular Taxonomy Group, Kamoun A, de Reyni?s A, Allory Y, Sj?dahl G, Groeneveld CS, Castro MAA, Fontugne J, Hartmann A, Malats N, Dyrskj?t L, H?glund M, Radvanyi F. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. 2020 04; 77(4):420-433. PMID: [31563503](//www.ncbi.nlm.nih.gov/pubmed/31563503); PMCID: [PMC7690647](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7690647).

Citations:
[217](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31563503/citedby/)
Fields:

Uro Urology

Translation:Humans

  19. Lee YC, Kurtova AV, Xiao J, Nikolos F, Hayashi K, Tramel Z, Jain A, Chen F, Chokshi M, Lee C, Bao G, Zhang X, Shen J, Mo Q, Jung SY, [Rowley D](https://profiles.viictr.org/profile/269631), **Chan KS**. Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung. Nat Commun. 2019 05 13; 10(1):2131. PMID: [31086186](//www.ncbi.nlm.nih.gov/pubmed/31086186); PMCID: [PMC6513865](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6513865).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31086186/citedby/) Fields:

Bio BiologySci Science

Translation:HumansAnimalsCells

  20. Mo Q, Nikolos F, Chen F, Tramel Z, Lee YC, Hayashi K, Xiao J, Shen J, **Chan KS**. Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas. J Natl Cancer Inst. 2018 05 01; 110(5):448-459. PMID: [29342309](//www.ncbi.nlm.nih.gov/pubmed/29342309); PMCID: [PMC6279371](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6279371).

Citations:
[50](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29342309/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  21. Mo Q, Shen R, Guo C, Vannucci M, **Chan KS** , [Hilsenbeck SG](https://profiles.viictr.org/profile/268374). A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data. Biostatistics. 2018 01 01; 19(1):71-86. PMID: [28541380](//www.ncbi.nlm.nih.gov/pubmed/28541380); PMCID: [PMC6455926](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6455926).

Citations:
[47](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28541380/citedby/) Fields:

Sta Statistics as Topic

Translation:Humans

  22. Rodriguez-Brenes IA, Kurtova AV, Lin C, Lee YC, Xiao J, Mims M, **Chan KS** , Wodarz D. Cellular Hierarchy as a Determinant of Tumor Sensitivity to Chemotherapy. Cancer Res. 2017 05 01; 77(9):2231-2241. PMID: [28235762](//www.ncbi.nlm.nih.gov/pubmed/28235762); PMCID: [PMC5487257](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5487257).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28235762/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  23. Brooks M, Mo Q, Krasnow R, Ho PL, Lee YC, Xiao J, Kurtova A, [Lerner S](https://profiles.viictr.org/profile/267959), [Godoy G](https://profiles.viictr.org/profile/267612), Jian W, [Castro P](https://profiles.viictr.org/profile/268709), Chen F, [Rowley D](https://profiles.viictr.org/profile/269631), [Ittmann M](https://profiles.viictr.org/profile/269566), **Chan KS**. Positive association of collagen type I with non-muscle invasive bladder cancer progression. Oncotarget. 2016 Dec 13; 7(50):82609-82619. PMID: [27655672](//www.ncbi.nlm.nih.gov/pubmed/27655672); PMCID: [PMC5347718](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5347718).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27655672/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  24. [Lerner SP](https://profiles.viictr.org/profile/267959), McConkey DJ, Hoadley KA, **Chan KS** , Kim WY, Radvanyi F, H?glund M, Real FX. Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting. Bladder Cancer. 2016 Jan 07; 2(1):37-47. PMID: [27376123](//www.ncbi.nlm.nih.gov/pubmed/27376123); PMCID: [PMC4927916](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4927916).

Citations:
[79](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27376123/citedby/)

  25. **Chan KS**. Molecular Pathways: Targeting Cancer Stem Cells Awakened by Chemotherapy to Abrogate Tumor Repopulation. Clin Cancer Res. 2016 Feb 15; 22(4):802-6. PMID: [26671994](//www.ncbi.nlm.nih.gov/pubmed/26671994); PMCID: [PMC4915779](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4915779).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26671994/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  26. Kurtova AV, Xiao J, Mo Q, Pazhanisamy S, Krasnow R, [Lerner SP](https://profiles.viictr.org/profile/267959), Chen F, Roh TT, Lay E, Ho PL, **Chan KS**. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature. 2015 Jan 08; 517(7533):209-13. PMID: [25470039](//www.ncbi.nlm.nih.gov/pubmed/25470039); PMCID: [PMC4465385](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4465385).

Citations:
[253](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25470039/citedby/)
Fields:

Sci Science

Translation:HumansAnimalsCells

  27. Kim W, Barron DA, San Martin R, **Chan KS** , Tran LL, [Yang F](https://profiles.viictr.org/profile/265773), Ressler SJ, [Rowley DR](https://profiles.viictr.org/profile/269631). RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation. Proc Natl Acad Sci U S A. 2014 Nov 18; 111(46):16389-94. PMID: [25313057](//www.ncbi.nlm.nih.gov/pubmed/25313057); PMCID: [PMC4246299](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4246299).

Citations:
[55](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25313057/citedby/) Fields:

Sci Science

Translation:HumansAnimalsCells

  28. Ho PL, Kurtova A, **Chan KS**. Normal and neoplastic urothelial stem cells: getting to the root of the problem. Nat Rev Urol. 2012 Oct; 9(10):583-94. PMID: [22890301](//www.ncbi.nlm.nih.gov/pubmed/22890301); PMCID: [PMC3468664](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3468664).

Citations:
[85](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22890301/citedby/) Fields:

Uro Urology

Translation:HumansCells

  29. Ho PL, Lay EJ, Jian W, Parra D, **Chan KS**. Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer. Cancer Res. 2012 Jul 01; 72(13):3135-42. PMID: [22532166](//www.ncbi.nlm.nih.gov/pubmed/22532166); PMCID: [PMC3418917](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3418917).

Citations:
[66](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22532166/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  30. Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB, Pazhanisamy SK, Contreras-Trujillo H, Storm TA, Lotan Y, Beck AH, Chung BI, Alizadeh AA, [Godoy G](https://profiles.viictr.org/profile/267612), [Lerner SP](https://profiles.viictr.org/profile/267959), van de Rijn M, Shortliffe LD, Weissman IL, **Chan KS**. Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci U S A. 2012 Feb 07; 109(6):2078-83. PMID: [22308455](//www.ncbi.nlm.nih.gov/pubmed/22308455); PMCID: [PMC3277552](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3277552).

Citations:
[122](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22308455/citedby/)
Fields:

Sci Science

Translation:HumansCells

  31. **Chan KS** , Volkmer JP, Weissman I. Cancer stem cells in bladder cancer: a revisited and evolving concept. Curr Opin Urol. 2010 Sep; 20(5):393-7. PMID: [20657288](//www.ncbi.nlm.nih.gov/pubmed/20657288); PMCID: [PMC2997612](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2997612).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20657288/citedby/) Fields:

Uro Urology

Translation:HumansAnimalsCells

  32. **Chan KS** , Espinosa I, Chao M, Wong D, Ailles L, Diehn M, Gill H, Presti J, Chang HY, van de Rijn M, Shortliffe L, Weissman IL. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A. 2009 Aug 18; 106(33):14016-21. PMID: [19666525](//www.ncbi.nlm.nih.gov/pubmed/19666525); PMCID: [PMC2720852](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2720852).

Citations:
[292](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19666525/citedby/)
Fields:

Sci Science

Translation:HumansAnimalsCells

  33. **Chan KS** , Sano S, Kataoka K, Abel E, Carbajal S, Beltran L, Clifford J, Peavey M, [Shen J](https://profiles.viictr.org/profile/12583333), Digiovanni J. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis. Oncogene. 2008 Feb 14; 27(8):1087-94. PMID: [17700521](//www.ncbi.nlm.nih.gov/pubmed/17700521).

Citations:
[51](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17700521/citedby/) Fields:

Mol Molecular BiologyNeo Neoplasms

Translation:AnimalsCells

  34. Kim DJ, **Chan KS** , Sano S, Digiovanni J. Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis. Mol Carcinog. 2007 Aug; 46(8):725-31. PMID: [17610223](//www.ncbi.nlm.nih.gov/pubmed/17610223).

Citations:
[56](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17610223/citedby/) Fields:

Mol Molecular BiologyNeo Neoplasms

Translation:HumansAnimals

  35. Sano S, **Chan KS** , DiGiovanni J. Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci. 2008 Apr; 50(1):1-14. PMID: [17601706](//www.ncbi.nlm.nih.gov/pubmed/17601706).

Citations:
[62](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17601706/citedby/) Fields:

Der Dermatology

Translation:HumansAnimals

  36. Sano S, **Chan KS** , Kira M, Kataoka K, Takagi S, Tarutani M, Itami S, Kiguchi K, Yokoi M, Sugasawa K, Mori T, Hanaoka F, Takeda J, DiGiovanni J. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res. 2005 Jul 01; 65(13):5720-9. PMID: [15994947](//www.ncbi.nlm.nih.gov/pubmed/15994947).

Citations:
[38](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15994947/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  37. Sano S, **Chan KS** , Carbajal S, Clifford J, Peavey M, Kiguchi K, Itami S, Nickoloff BJ, DiGiovanni J. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med. 2005 Jan; 11(1):43-9. PMID: [15592573](//www.ncbi.nlm.nih.gov/pubmed/15592573).

Citations:
[208](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15592573/citedby/)
Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansAnimalsCells

  38. **Chan KS** , Sano S, Kiguchi K, Anders J, Komazawa N, Takeda J, DiGiovanni J. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest. 2004 Sep; 114(5):720-8. PMID: [15343391](//www.ncbi.nlm.nih.gov/pubmed/15343391); PMCID: [PMC514583](//www.ncbi.nlm.nih.gov/pmc/articles/PMC514583).

Citations:
[170](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15343391/citedby/)
Fields:

Med Medicine (General)

Translation:Animals

  39. **Chan KS** , Carbajal S, Kiguchi K, Clifford J, Sano S, DiGiovanni J. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res. 2004 Apr 01; 64(7):2382-9. PMID: [15059889](//www.ncbi.nlm.nih.gov/pubmed/15059889).

Citations:
[76](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15059889/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 39 publications over 17 distinct years, with a maximum of
7 publications in
2022](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|7&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,43,14,0,43,0,14,14,0,43,0,29,14,29,14,29,43,43,43,100,14,29&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2004| 3  
2005| 1  
2007| 3  
2009| 1  
2010| 1  
2012| 3  
2014| 2  
2015| 1  
2016| 2  
2017| 1  
2018| 2  
2019| 3  
2020| 3  
2021| 3  
2022| 7  
2023| 1  
2024| 2  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

CHAN's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (185)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Urinary Bladder Neoplasms](https://profiles.viictr.org/profile/251465)
  * [Neoplastic Stem Cells](https://profiles.viictr.org/profile/244630)
  * [Urothelium](https://profiles.viictr.org/profile/241353)
  * [Carcinoma, Transitional Cell](https://profiles.viictr.org/profile/257285)
  * [Tumor Microenvironment](https://profiles.viictr.org/profile/27546258)

[Explore](https://profiles.viictr.org/profile/266205/198)

_

Co-Authors (16)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [LERNER, SETH](https://profiles.viictr.org/profile/267959)
  * [ROWLEY, DAVID](https://profiles.viictr.org/profile/269631)
  * [GODOY, GUILHERME](https://profiles.viictr.org/profile/267612)
  * [LIN, WEEI-CHIN](https://profiles.viictr.org/profile/266112)
  * [HO, SHIUH-RONG](https://profiles.viictr.org/profile/3009889)

[Explore](https://profiles.viictr.org/profile/266205/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [KAMAT, ASHISH](https://profiles.viictr.org/profile/12582620)
  * [DINNEY, COLIN P](https://profiles.viictr.org/profile/12583684)
  * [LERNER, SETH](https://profiles.viictr.org/profile/267959)
  * [SIEFKER-RADTKE, ARLENE ODELIA](https://profiles.viictr.org/profile/12582595)
  * [CZERNIAK, BOGDAN A](https://profiles.viictr.org/profile/12582882)

[Explore](https://profiles.viictr.org/profile/266205/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [BRINKLEY, BILL R.](https://profiles.viictr.org/profile/267367)
  * [GOODELL, MARGARET](https://profiles.viictr.org/profile/269806)
  * [HODGES, H.](https://profiles.viictr.org/profile/22247958)
  * [MAO, JIANQIANG](https://profiles.viictr.org/profile/269646)
  * [SUESS, PATRICK](https://profiles.viictr.org/profile/40252767)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [CATE, THOMAS](https://profiles.viictr.org/profile/267238)
  * [DE PAIVA, CINTIA](https://profiles.viictr.org/profile/268002)
  * [DICKERSON, HEATHER](https://profiles.viictr.org/profile/267035)
  * [HOLDER JR, JIMMY](https://profiles.viictr.org/profile/267458)
  * [JARJOUR, IMAD](https://profiles.viictr.org/profile/270288)

_

